These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Cutaneous immunization: an evolving paradigm in influenza vaccines. Gill HS; Kang SM; Quan FS; Compans RW Expert Opin Drug Deliv; 2014 Apr; 11(4):615-27. PubMed ID: 24521050 [TBL] [Abstract][Full Text] [Related]
31. Intradermal delivery for vaccine dose sparing: overview of current issues. Zehrung D; Jarrahian C; Wales A Vaccine; 2013 Jul; 31(34):3392-5. PubMed ID: 23176978 [TBL] [Abstract][Full Text] [Related]
32. Multifunctional particle-constituted microneedle arrays as cutaneous or mucosal vaccine adjuvant-delivery systems. Wang X; Wang N; Li N; Zhen Y; Wang T Hum Vaccin Immunother; 2016 Aug; 12(8):2075-2089. PubMed ID: 27159879 [TBL] [Abstract][Full Text] [Related]
33. pH Sensitive phosphorylated chitosan hydrogel as vaccine delivery system for intramuscular immunization. Wei J; Xue W; Yu X; Qiu X; Liu Z J Biomater Appl; 2017 May; 31(10):1358-1369. PubMed ID: 28387574 [TBL] [Abstract][Full Text] [Related]
34. Efficient antigen delivery to the draining lymph nodes is a key component in the immunogenic pathway of the intradermal vaccine. Tozuka M; Oka T; Jounai N; Egawa G; Ishii KJ; Kabashima K; Takeshita F J Dermatol Sci; 2016 Apr; 82(1):38-45. PubMed ID: 26674124 [TBL] [Abstract][Full Text] [Related]
35. Transcutaneous immunization: an overview of advantages, disease targets, vaccines, and delivery technologies. Karande P; Mitragotri S Annu Rev Chem Biomol Eng; 2010; 1():175-201. PubMed ID: 22432578 [TBL] [Abstract][Full Text] [Related]
36. Emerging skin-targeted drug delivery strategies to engineer immunity: A focus on infectious diseases. Korkmaz E; Balmert SC; Carey CD; Erdos G; Falo LD Expert Opin Drug Deliv; 2021 Feb; 18(2):151-167. PubMed ID: 32924651 [TBL] [Abstract][Full Text] [Related]
37. Vaccine self-assembling immune matrix is a new delivery platform that enhances immune responses to recombinant HBsAg in mice. Grenfell RF; Shollenberger LM; Samli EF; Harn DA Clin Vaccine Immunol; 2015 Mar; 22(3):336-43. PubMed ID: 25609075 [TBL] [Abstract][Full Text] [Related]
38. Natural STING Agonist as an "Ideal" Adjuvant for Cutaneous Vaccination. Wang J; Li P; Wu MX J Invest Dermatol; 2016 Nov; 136(11):2183-2191. PubMed ID: 27287182 [TBL] [Abstract][Full Text] [Related]
39. Hyaluronan-based dissolving microneedles with high antigen content for intradermal vaccination: Formulation, physicochemical characterization and immunogenicity assessment. Leone M; Priester MI; Romeijn S; Nejadnik MR; Mönkäre J; O'Mahony C; Jiskoot W; Kersten G; Bouwstra JA Eur J Pharm Biopharm; 2019 Jan; 134():49-59. PubMed ID: 30453025 [TBL] [Abstract][Full Text] [Related]